Targeting RIPK1 for the treatment of depression: From neuroinflammation to synaptic plasticity

Biochemical Pharmacology · Published 2026-07-10 · DOI 10.1016/j.bcp.2026.118230

Authors (3)

Xiao-Qun Chen, Yu-Chi Zhuang, Wei Guan

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Chen, X., Zhuang, Y., Guan, W. (2026). Targeting RIPK1 for the treatment of depression: From neuroinflammation to synaptic plasticity. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2026.118230

Related articles

• BiP-engaging xanthones from the mangosteen (Garcinia mangostana) induce androgen receptor degradation in prostate cancer cells · Biochemical Pharmacology · 2026 · Same journal
• Advanced therapy medicinal products for local treatment using new delivery methods · Biochemical Pharmacology · 2026 · Same journal
• Genetic polymorphisms of drug-metabolizing cytochromes P450 and flavin-containing monooxygenases in dogs and pigs inform the prediction of drug metabolism and toxicity in humans and other animal species · Biochemical Pharmacology · 2026 · Same journal
• CerS2/ceramide C24:1/ROCK2 signaling-mediated angiogenesis protects against ischemic brain injury in mice · Biochemical Pharmacology · 2026 · Same journal
• Core genes drive treatment resistance in triple-negative breast cancer: characteristics, mechanisms, intervention strategies · Biochemical Pharmacology · 2026 · Same journal
• HDAC1-mediated PKM2 delactylation modification regulates CIRP-induced angiogenesis in rheumatoid arthritis · Biochemical Pharmacology · 2026 · Same journal
• Orforglipron alleviates aortic aneurysm and dissection via inhibiting WNT5A noncanonical signaling · Biochemical Pharmacology · 2026 · Same journal
• Glycoprotein nonmetastatic B as a pharmacological target in cancer: structural mechanisms, druggability, and therapeutic translation · Biochemical Pharmacology · 2026 · Same journal
• Quercetin induces ferroptosis in ovarian cancer by suppressing the NRF2/HO‑1/GPX4 axis and increasing the efficacy of cisplatin · Biochemical Pharmacology · 2026 · Same journal
• MYH11 upregulation attenuates autophagy dysfunction through modulation of ATG4A in metabolic dysfunction-associated steatotic liver disease · Biochemical Pharmacology · 2026 · Same journal